论文部分内容阅读
背景:在对发生呼吸窘迫综合征的早产儿的临床处置工作中,对于经鼻呼吸道持续正压呼吸(nCPAP)的疗效,人们尚未彻底阐明。目的:评估预防性经鼻持续正压通气(nCPAP)对于胎龄为28-31周的新生儿的治疗价值及其危险性。试验设计:多中心随机临床对照试验。机
BACKGROUND: In the clinical management of preterm infants with respiratory distress syndrome, the efficacy of continuous positive pressure breathing (nCPAP) in the nasal respiratory tract has not yet been fully elucidated. PURPOSE: To evaluate the therapeutic value and risk of prophylactic nCPAP in neonates with gestational age of 28-31 weeks. Trial Design: A Multicenter Randomized Controlled Trial. machine